Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
The RFT Group is seeking a Senior Clinical Supply Chain Manager to lead end-to-end IMP and study device supply for global trials. Working in a fully virtual manufacturing model, you will own the supply lifecycle from demand forecasting to final distribution and destruction, reporting to the CSC Director.
The role requires 6–9 years in clinical supply chain with 2–3 years in senior/lead responsibility for Phase 3 IMP supply, strong IRT experience (Suvoda preferred), and proven vendor governance
Our client is a young exciting publicly listed clinical-stage company dedicated to transforming the lives of patients within its therapy areas. With its novel and proprietary drug products and current clinical development programs our client is aiming to provide improved treatments for patients with increased remission rates, faster onset of action, durable effects, and improved tolerability and convenience. This requires experience and a track record of successful development in complex and innovative areas, and excitement for creating something new and ground breaking.
Role is hybrid based, across Ireland, The UK, Italy, Spain or Belgium.
Applicants MUST HAVE 6–9 years in clinical supply chain, of which at least 2–3 in a senior or lead role with direct Phase 3 IMP supply accountability
This experienced Senior Clinical Supply Chain Manager (SCM) will lead end-to-end investigational medicinal product (IMP) and study device supply for early to late-stage global studies. Operating in a fully virtual manufacturer model, they will own the complete clinical supply lifecycle — from demand forecasting and vendor management through to controlled drug compliance, distribution, returns and destruction.
Reporting directly to the Clinical Supply Chain Director, this is a senior, autonomous role requiring the confidence to manage complex vendor relationships and represent the business in governance forums independently. They will own the study-level supply chain Gantt, risk register and budget, and work as a close peer to the Senior CSC Manager leading the upstream CMC and device supply planning. The role may also include acting as line management for more junior SCM roles.
Demonstrated end-to-end ownership of IMP and/or device supply chains in a Phase 1-3 clinical context, including depot management, distribution and site supply across multiple geographies
Hands‑on experience with clinical IRT systems (Suvoda preferred; equivalents considered); direct experience managing UAT, lot release testing and resupply configuration
Practical experience managing IMP packaging campaigns and label management across EU CTR and FDA 21 CFR Part 312 frameworks; label version control and change management
Working knowledge of Schedule I (or equivalent) CD licence requirements across US (DEA), EU national authorities and UK Home Office; import/export licence management and depot licence oversight
Track record managing multi-country IMP and device distribution and returns management including depot oversight, cross-border import/export and courier management
Familiarity with TMF structure and supply chain document filing obligations under ICH E6(R3) and EU CTR
Experience managing clinical supply chains in a virtual pharmaceutical company with outsourced manufacturing, packaging and distribution
Credible, independent operator capable of managing senior vendor relationships and representing in governance forums
6–9 years in clinical supply chain, of which at least 2–3 in a senior or lead role with direct Phase 3 IMP supply accountability
Degree in life sciences, pharmacy, supply chain or a related discipline; postgraduate qualification advantageous